|
WO2021072225A1
|
|
Modulating interleukin-10 signaling to boost healing in diabetic wounds
|
|
US2021085336A1
|
|
Focal Pressure Applicator to Cease Bleeding
|
|
WO2021046081A1
|
|
Methods and compositions for treatment of demyelinating disorders
|
|
WO2021011500A2
|
|
Use of a benzoate containing composition to treat neurodegenerative disorders
|
|
WO2020205827A1
|
|
Reagents and assays using modified integrin domains
|
|
WO2020197967A1
|
|
Combination of nasal gene delivery and oral cinnamic acid, oleamide or gemfibrozil for lysosomal stoarge disorders
|
|
WO2020176432A1
|
|
Compositions including cinnamic acid and methods of use thereof
|
|
WO2020112776A1
|
|
Telemetry electrodes for continuous atrial electrogram monitoring
|
|
WO2020097028A1
|
|
Nasal delivery of low-dose aspirin for the treatment of neurodegenerative and lysosomal storage diseases
|
|
WO2020068751A1
|
|
Ventilation adaptor and method of use thereof
|
|
AU2019310018A1
|
|
Inhibition of kidney disease relapse by targeted cytokine depletion
|
|
CA3111339A1
|
|
Use of immunomodulators to control infection and stimulate healing in normal and diabetic wounds
|
|
WO2019246019A1
|
|
Use of apoptotic compensatory proliferation signaling vesicles in tissue repair and wound healing
|
|
WO2019241386A1
|
|
Methods for enhanced endothelialization of implanted material
|
|
WO2019241339A1
|
|
Compositions and methods of treatment for chronic rhinosinusitis
|
|
WO2019236555A1
|
|
Positioning device and method of use thereof
|
|
KR20210024488A
|
|
ICOSL for use as a kidney treatment
|
|
WO2019213217A1
|
|
Methods and compositions for treatment of cancer with parp inhibitors
|
|
WO2019210192A1
|
|
Use of methylation inhibitors for the treatment of autoimmune diseases
|
|
EP3776135A1
|
|
Method of treatment utilizing a gene expression signature predicting the response of her2-directed therapies
|
